Literature DB >> 3726997

A histopathological analysis of the course of myocarditis in C3H/He mice infected with Trypanosoma cruzi clone Sylvio-X10/4.

M Postan, A W Cheever, J A Dvorak, J P McDaniel.   

Abstract

The histopathology of hearts of C3H/He (MTV-) mice infected for 2 to 440 days with Trypanosoma cruzi clone Sylvio-X10/4 was examined. Inflammation was present in most hearts at 14 days post-infection (d.p.i.) and persisted thereafter. Myocardial fibrosis, which was first seen 45 d.p.i. and was more marked after 200 d.p.i., developed at a time when few parasites were present. Fibrosis predominated in subepicardial and subendocardial myocardium, areas of most severe inflammation. Parasites were restricted to myocardial fibres and were found in all mice infected for 14 to 30 days and, in fewer numbers, in 54% of mice infected for more than 30 days. T. cruzi-induced myocarditis in mice was not a self-resolving disease but a dynamic, active process occurring continuously over a long time following infection. This clone-derived T. cruzi stock produced a myocarditis in inbred mice similar to that seen in human chronic Chagas' disease.

Entities:  

Mesh:

Year:  1986        PMID: 3726997     DOI: 10.1016/0035-9203(86)90193-8

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase.

Authors:  F S Buckner; A J Wilson; W C Van Voorhis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi.

Authors:  L V Kirchhoff; J R Votava; D E Ochs; D R Moser
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue.

Authors:  R L Tarleton; L Zhang; M O Downs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  ECG detection of murine chagasic cardiomyopathy.

Authors:  Christopher S Eickhoff; Cade T Lawrence; John E Sagartz; Leesa A Bryant; Arthur J Labovitz; Simil S Gala; Daniel F Hoft
Journal:  J Parasitol       Date:  2010-08       Impact factor: 1.276

6.  Mice with Genetic Deletion of Group VIA Phospholipase A2β Exhibit Impaired Macrophage Function and Increased Parasite Load in Trypanosoma cruzi-Induced Myocarditis.

Authors:  Janhavi Sharma; Jennifer R Blase; Daniel F Hoft; John O Marentette; John Turk; Jane McHowat
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

7.  Macrophages Promote Oxidative Metabolism To Drive Nitric Oxide Generation in Response to Trypanosoma cruzi.

Authors:  Sue-Jie Koo; Imran H Chowdhury; Bartosz Szczesny; Xianxiu Wan; Nisha J Garg
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

8.  A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase.

Authors:  Lars Ny; Hua Li; Shankar Mukherjee; Katarina Persson; Bo Holmqvist; Dazhi Zhao; Vitaliy Shtutin; Huan Huang; Louis M Weiss; Fabiana S Machado; Stephen M Factor; John Chan; Herbert B Tanowitz; Linda A Jelicks
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

9.  Granulocyte colony-stimulating factor partially repairs the damage provoked by Trypanosoma cruzi in murine myocardium.

Authors:  Mariela Natacha González; Nilay Dey; Nisha Jain Garg; Miriam Postan
Journal:  Int J Cardiol       Date:  2013-04-15       Impact factor: 4.164

10.  Sudden death related myocarditis: a study of 56 cases.

Authors:  Indira D Kitulwatte; Patrick J H Kim; Michael S Pollanen
Journal:  Forensic Sci Med Pathol       Date:  2009-11-29       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.